Reduced glycogen synthase activity in skeletal muscle from obese patients with and without type 2 (non-insulin-dependent) diabetes mellitus

P Damsbo, A Vaag, O Hother-Nielsen, H Beck-Nielsen - Diabetologia, 1991 - Springer
P Damsbo, A Vaag, O Hother-Nielsen, H Beck-Nielsen
Diabetologia, 1991Springer
In order to evaluate the importance of a defect in insulin mediated non-oxidative glucose
metabolism and glycogen synthase activity in skeletal muscles in obese subjects with and
without Type 2 (non-insulin-dependent) diabetes mellitus we studied: 10 lean and 10 obese
control subjects and 12 obese diabetic patients using the euglycaemic hyperinsulinaemic
clamp technique (basal, 20 mU·(m 2)− 1· min− 1, 80mU·(m 2)− 1· min− 1) in combination
with indirect calorimetry. Muscle biopsies were taken from m. vastus lateralis at each insulin …
Summary
In order to evaluate the importance of a defect in insulin mediated non-oxidative glucose metabolism and glycogen synthase activity in skeletal muscles in obese subjects with and without Type 2 (non-insulin-dependent) diabetes mellitus we studied: 10 lean and 10 obese control subjects and 12 obese diabetic patients using the euglycaemic hyperinsulinaemic clamp technique (basal, 20 mU · (m2)−1 · min−1, 80mU·(m2)−1·min−1) in combination with indirect calorimetry. Muscle biopsies were taken from m. vastus lateralis at each insulin level. We found that non-oxidative glucose metabolism could be stimulated by insulin in all three groups (p<0.01). The values obtained at the highest insulin levels (around 140 μU/ml) were lower in both obese groups compared to the lean control subjects (118±21, 185±31, 249±14 mg·(m2)−1·min−1 (p< 0.01)). Insulin stimulation of the glycogen synthase activity at a glucose-6-phosphate concentration of 0.1 mmol/l was absent in both obese groups, while activities increased significantly in the lean control subjects (19.6±4.2% to 45.6±6.8%, p< 0.01). Glycogen synthase activities at the highest insulin concentrations only differed significantly between lean control subjects and obese diabetic patients (45±7% and 31±5%, p< 0.05). We conclude that insulin resistance in peripheral tissues in obese subjects with and without Type 2 diabetes may be partly explained by a reduced insulin mediated non-oxidative glucose metabolism and that this abnormality might be due to an absent insulin stimulation of glycogen synthase in skeletal muscles. This enzyme defect is correlated to obesity itself.
Springer